Primer: BillionToOne (BLLN US) - Aug 2026
BillionToOne is a rapidly growing, recently profitable molecular diagnostics company poised to disrupt the prenatal and oncology testing...
91 Views
𝛼SK or SearchENTITY
BillionToOne (BLLN US)
BillionToOne (BLLN US)
20
Analysis
Health Care • United States
BillionToOne, Inc. operates as a diagnostics company. The Company provides quantitative counting templates that detects genetic disorders in the developing baby from maternal blood, as well as invents in the patent-pending molecular counter platform, which increases the resolution of cell-free DNA detection. BillionToOne serves customers in the United States.
morex